SOTERA HEALTH COMPANY
Income Statement
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | $1.16B | $1.10B | $1.05B | $1.00B | $931.5M | $818.2M | $778.3M |
| Cost of Revenue | — | $518.1M | $498.1M | $472.1M | $446.7M | $412.8M | $374.6M | $382.9M |
| Gross Profit | — | $645.5M | $602.3M | $577.2M | $557.0M | $518.7M | $443.6M | $395.4M |
| Gross Margin | — | 55.5% | 54.7% | 55.0% | 55.5% | 55.7% | 54.2% | 50.8% |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | — | $252.8M | $242.6M | $236.7M | $245.7M | $198.2M | $178.5M | $147.5M |
| Operating Income | — | $147.5M | $297.6M | $276.7M | $248.4M | $256.7M | $206.0M | $183.6M |
| Operating Margin | — | 12.7% | 27.0% | 26.4% | 24.7% | 27.6% | 25.2% | 23.6% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | — | $147.5M | $113.9M | $106.0M | $-243.1M | $175.7M | $-38.9M | $-916.0K |
| Income Tax Expense | — | $69.6M | $69.5M | $54.7M | $-9.5M | $58.6M | $-1.4M | $19.5M |
| Net Income | — | $77.9M | $44.4M | $51.4M | $-233.6M | $116.9M | $-38.6M | $-20.9M |
| Net Margin | — | 6.7% | 4.0% | 4.9% | -23.3% | 12.5% | -4.7% | -2.7% |
| EPS (Basic) | — | $0.27 | $0.16 | $0.18 | $-0.83 | $0.41 | $-0.16 | $-0.09 |
| EPS (Diluted) | — | $0.27 | $0.16 | $0.18 | $-0.83 | $0.41 | $-0.16 | $-0.09 |
| Shares Outstanding (Basic) | 284.4M | 284.0M | 282.8M | 281.0M | 280.1M | 279.2M | 237.7M | 232.4M |
| Shares Outstanding (Diluted) | 284.4M | 286.4M | 284.9M | 283.2M | 280.1M | 279.4M | 237.7M | 232.4M |
| Dividends Per Share | — | — | — | — | — | — | — | — |